Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
Popular Children's Snack Recalled As FDA Sets Highest Concern Level
Brand of snacks popular with children was recalled due to undeclared milk. FDA classified the recall at the highest risk ...
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Hospitals take steps to conserve IV fluid supply after Helene strikes critical factory
Baxter International said it would temporarily close production at its North Cove, North Carolina-based facility, raising ...
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...
Eat first, test later: How the FDA’s food regulatory system is broken
A regulatory loophole allows manufacturers to add untested ingredients to food that are later found to be dangerous. Here’s ...
How untested ingredients enter the food you eat
A regulatory loophole allows manufacturers to add untested ingredients to food that are later found to be dangerous. Here’s ...
Is the food in the fridge still good? California wants to end the guessing game
The new law will require the use of “Best if Used By” label to signal peak quality and “Use By” label for product safety.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
Lilly's weight-loss, diabetes drugs no longer in shortage, pressuring Hims and Hers' stock
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...